The parenteral contract manufacturing organization (CMO) has signed purchase agreements to acquire a 1.5-acre lot on Butterworth Street in Grand Rapids, Michigan.
The new site is less than a quarter mile away from GRAM's existing manufacturing facility near downtown Grand Rapids and less than a mile away from its finishing facility on Godfrey Street.
“The land purchase will support GRAM’s new, high-speed commercial scale equipment,” said Nick Bykerk, the company’s director of business development and finance.
GRAM’s continued growth with its current customers and their commercial needs as well as overall growth in the market has driven demand for the expansion, Tom Ross, GRAM president and CEO told us.
The new site will increase GRAM’s existing 40,000-square-foot cGMP space and will eventually house cleanroom space, including new isolator technology and fully integrated manufacturing and packaging lines.
The next steps involve groundbreaking, qualifying the new equipment, and launch in 2020, Ross explained. The deal is expected to close within 90 days.
GRAM, formed in 2010, also expanded its fill/finish footprint in 2014 with the addition of a 28,000-square-foot facility. It has grown from 16 employees to more than 160 over the past seven years.